Envestnet Asset Management
ASND icon

Envestnet Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Envestnet Asset Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2M Buy
+45,776
New +$10.7M ﹤0.01% 1798
2026
Q1 		– Sell
-16,338
Closed -$3.48M – 4708
2025
Q4 		$3.48M Sell
16,338
-8,624
-35% -$1.78M ﹤0.01% 2434
2025
Q3 		$4.96M Buy
24,962
+3,232
+15% +$603K ﹤0.01% 2245
2025
Q2 		$3.75M Buy
21,730
+9,879
+83% +$1.61M ﹤0.01% 2392
2025
Q1 		$1.85M Buy
11,851
+1,274
+12% +$182K ﹤0.01% 2788
2024
Q4 		$1.46M Sell
10,577
-1,762
-14% -$232K ﹤0.01% 2898
2024
Q3 		$1.84M Buy
12,339
+1,692
+16% +$228K ﹤0.01% 2713
2024
Q2 		$1.45M Buy
10,647
+6,333
+147% +$862K ﹤0.01% 2784
2024
Q1 		$652K Buy
4,314
+527
+14% +$75.2K ﹤0.01% 3283
2023
Q4 		$477K Sell
3,787
-2,852
-43% -$284K ﹤0.01% 3354
2023
Q3 		$622K Buy
6,639
+1,757
+36% +$164K ﹤0.01% 3132
2023
Q2 		$436K Buy
4,882
+1,244
+34% +$108K ﹤0.01% 3288
2023
Q1 		$390K Buy
3,638
+135
+4% +$15.4K ﹤0.01% 3310
2022
Q4 		$428K Buy
3,503
+277
+9% +$32.2K ﹤0.01% 3184
2022
Q3 		$333K Buy
3,226
+105
+3% +$9.96K ﹤0.01% 3275
2022
Q2 		$290K Buy
3,121
+875
+39% +$82.5K ﹤0.01% 3376
2022
Q1 		$264K Buy
2,246
+282
+14% +$32.7K ﹤0.01% 3524
2021
Q4 		$264K Sell
1,964
-7,963
-80% -$1.18M ﹤0.01% 3486
2021
Q3 		$1.58M Buy
9,927
+193
+2% +$26.4K ﹤0.01% 2247
2021
Q2 		$1.28M Buy
9,734
+714
+8% +$95.1K ﹤0.01% 2360
2021
Q1 		$1.16M Sell
9,020
-6,200
-41% -$942K ﹤0.01% 2291
2020
Q4 		$2.54M Sell
15,220
-1,255
-8% -$208K ﹤0.01% 1625
2020
Q3 		$2.54M Sell
16,475
-6,066
-27% -$872K ﹤0.01% 1486
2020
Q2 		$3.33M Buy
+22,541
New +$3.09M ﹤0.01% 1322

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Envestnet Asset Management's ASND Position: Q2 2026 in Review

Envestnet Asset Management opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 45,776 shares worth $12.2M. The stake represents ﹤0.01% of the portfolio and ranks #1798 among its holdings. This is a return to the name: Envestnet Asset Management previously reported a position in ASND as recently as Q4 2025.

Envestnet Asset Management first reported a position in ASND in Q2 2020 and has held it in 24 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Envestnet Asset Management held 45,776 shares of Ascendis Pharma A/S worth $12.2M as of Q2 2026.
  • Ascendis Pharma A/S was a new Envestnet Asset Management position in Q2 2026.
  • Ascendis Pharma A/S made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1798 holding.
  • Envestnet Asset Management first reported a position in Ascendis Pharma A/S in Q2 2020 and has held it in 24 quarters since.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.